Phathom Pharmaceuticals | 10-Q: Quarterly report
Phathom Pharmaceuticals | 8-K: Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Phathom Pharmaceuticals | DEF 14A: Definitive information statements
Phathom Pharmaceuticals | DEFA14A: Others
Phathom Pharmaceuticals | ARS: Annual Report to Security Holders
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Henderson Molly
Phathom Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Takeda Pharmaceutical Company Limited(4.8%)
Phathom Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Takeda Pharmaceutical Company Limited(5.4%)
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Curran Terrie
Phathom Pharmaceuticals | 10-K: Annual report
Phathom Pharmaceuticals | 8-K: Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Phathom Pharmaceuticals | 8-K: Current report
Phathom Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Carlyle Group Inc.(6.1%),Carlyle Holdings I GP Inc.(6.1%), etc.
Phathom Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invesco Ltd.(5.5%)
Phathom Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner Medicxi Ventures Management (Jersey) Ltd
Phathom Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Medicxi Ventures Management (Jersey) Limited(13.0%),Medicxi Growth I GP Limited(6.6%), etc.
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner TAKEDA PHARMACEUTICAL CO LTD
Phathom Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Takeda Pharmaceutical Company Limited(6.6%)
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nabulsi Azmi
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Curran Terrie
No Data